Back
Enliven Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
42
ELVN
Enliven Therapeutics
Last Price:
$17.75
Seasonality Move:
-14.53%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELVN is experiencing slight selling pressure.
Enliven Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.29 | Buy |
| 20-day SMA: | 18.61 | Buy |
| 50-day SMA: | 19.26 | Buy |
| 200-day SMA: | 22.75 | Sell |
| 8-day EMA: | 19.33 | Buy |
| 20-day EMA: | 18.97 | Buy |
| 50-day EMA: | 19.35 | Buy |
| 200-day EMA: | 21.17 | Sell |
Enliven Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 55.69 | Buy |
| Chaikin Money Flow: | -198785 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.71 - 19.65) | Buy |
| Bollinger Bands (100): | (18.62 - 22.6) | Sell |
Enliven Therapeutics Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enliven Therapeutics Stock
Is Enliven Therapeutics Stock a Buy?
-
Enliven Therapeutics share price is 19.89 while ELVN 8-day simple moving average is 19.29, which is a Buy signal.
-
The stock price of ELVN is 19.89 while Enliven Therapeutics 20-day SMA is 18.61, which makes it a Buy.
-
Enliven Therapeutics 50-day simple moving average is 19.26 while ELVN share price is 19.89, making it a Buy technically.
-
ELVN stock price is 19.89 and Enliven Therapeutics 200-day simple moving average is 22.75, creating a Sell signal.
ELVN Technical Analysis vs Fundamental Analysis
Sell
42
Enliven Therapeutics (ELVN)
is a Sell
Is Enliven Therapeutics a Buy or a Sell?
-
Enliven Therapeutics stock is rated a SellThe current Enliven Therapeutics [ELVN] share price is $19.89. The Score for ELVN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Enliven Therapeutics Stock Info
Market Cap:
974.7M
Price in USD:
19.89
Share Volume:
400.4K
Enliven Therapeutics 52-Week Range
52-Week High:
30.03
52-Week Low:
13.30
Sell
42
Enliven Therapeutics (ELVN)
is a Sell
Enliven Therapeutics Share Price Forecast
-
What is the Enliven Therapeutics stock price today?The Enliven Therapeutics stock price is 19.89 USD today.
-
Will ELVN stock go up or go down?Enliven Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Enliven Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enliven Therapeutics is overvalued.
Is Enliven Therapeutics Stock a Buy?
-
Enliven Therapeutics share price is 19.89 while ELVN 8-day exponential moving average is 19.33, which is a Buy signal.
-
The stock price of ELVN is 19.89 while Enliven Therapeutics 20-day EMA is 18.97, which makes it a Buy.
-
Enliven Therapeutics 50-day exponential moving average is 19.35 while ELVN share price is 19.89, making it a Buy technically.
-
ELVN stock price is 19.89 and Enliven Therapeutics 200-day simple moving average is 21.17, creating a Sell signal.
Fundamental Analysis of Enliven Therapeutics
Is Enliven Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Enliven Therapeutics
Should I short Enliven Therapeutics stock?
-
ELVN Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Enliven Therapeutics is a Buy
-
Enliven Therapeutics Relative Strength Index (RSI) is 55.69, which suggest Enliven Therapeutics is overbought
-
The Bollinger Bands (25) for Enliven Therapeutics is (16.71 - 19.65), which suggest Enliven Therapeutics is a Sell
-
The Bollinger Bands (100) for Enliven Therapeutics is (18.62 - 22.6), which suggest Enliven Therapeutics is a Sell
* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.